DE2064092C2
(de)
|
1970-12-28 |
1983-06-01 |
Bayer Ag, 5090 Leverkusen |
Inhibitoren für Glykosidhydrolasen aus Actinomyceten
|
US3937817A
(en)
|
1973-02-28 |
1976-02-10 |
Bayer Aktiengesellschaft |
Pharmaceutical compositions containing a saccharase inhibitor
|
US4016260A
(en)
|
1974-07-22 |
1977-04-05 |
Toyama Chemical Co., Ltd. |
Novel polypeptide produced by pseudomonas
|
FR2474829B1
(fr)
|
1980-02-01 |
1983-09-09 |
Agronomique Inst Nat Rech |
Procede de traitement d'une matiere a base de caseine contenant des phosphocaseinates de cations monovalents ou leurs derives, produits obtenus et applications
|
FR2474828B1
(fr)
|
1980-02-01 |
1983-09-09 |
Agronomique Inst Nat Rech |
Procede de traitement d'une matiere premiere a base de caseine, contenant des phosphocaseinates de cations bivalents, produits obtenus et application
|
US4491589A
(en)
|
1982-05-17 |
1985-01-01 |
The Trustees Of Columbia University In The City Of New York |
Amino acid solutions for parenteral nutrition and methods of formulation and use
|
DK589785A
(da)
|
1985-12-18 |
1987-06-19 |
Samuelsson Ernst Gunnar |
Peptidpraeparat, fremgangsmaade til fremstilling deraf samt anvendelse af peptidpraeparatet
|
IT1190349B
(it)
|
1986-06-16 |
1988-02-16 |
Prodotti Formenti Srl |
Composizioni farmaceutiche ad attivita' sequestrante degli acidi biliari contenenti colestiramina quale principio attivo,e procedimento per prepararle
|
FR2608050B1
(fr)
|
1986-12-15 |
1990-04-13 |
Bellon Labor Sa Roger |
Procede de preparation d'un melange peptidique riche en di- et tri-peptides, utilisable notamment en nutrition artificielle et en dietetique, melange ainsi obtenu, et utilisation de ce melange en nutrition artificielle et en dietetique
|
US5230902A
(en)
|
1988-04-29 |
1993-07-27 |
Immunotec Research Corporation |
Undenatured whey protein concentrate to improve active systemic humoral immune response
|
US5102871A
(en)
|
1989-04-24 |
1992-04-07 |
Kyowa Hakko Kogyo Co., Ltd. |
Nutrient composition
|
FI904074A0
(fi)
|
1989-08-28 |
1990-08-17 |
Milupa Ag |
Protein-, peptid- och aminosyrablandningar med optimerad aminosyrasammansaettning samt deras anvaendning foer framstaellning av naering foer prematur- och dibarn samt av tillsatser till modersmjoelk.
|
US5407957A
(en)
|
1990-02-13 |
1995-04-18 |
Martek Corporation |
Production of docosahexaenoic acid by dinoflagellates
|
PH30997A
(en)
|
1990-03-12 |
1997-12-23 |
Ciba Geigy |
Antipathologenically effective compositions comprising lytic peptides and hydrolytic enzymes.
|
ZA92452B
(en)
|
1991-01-24 |
1992-10-28 |
Martek Corp |
Microbial oil mixtures and uses thereof
|
US5308832A
(en)
|
1992-07-27 |
1994-05-03 |
Abbott Laboratories |
Nutritional product for persons having a neurological injury
|
GB9310472D0
(en)
|
1993-05-20 |
1993-07-07 |
Univ Warwick |
Phenylalanine-free protein and dna coding thereof
|
GB9312369D0
(en)
|
1993-06-16 |
1993-07-28 |
Sandoz Nutrition Ltd |
Organic compounds
|
US5405637A
(en)
|
1993-06-30 |
1995-04-11 |
Bristol-Myers Squibb Company |
Milk protein partial hydrolysate and infant formula containing same
|
US5723446A
(en)
|
1993-12-23 |
1998-03-03 |
Nestec Ltd. |
Enteral formulation designed for optimized nutrient absorption and wound healing
|
US5714472A
(en)
|
1993-12-23 |
1998-02-03 |
Nestec Ltd. |
Enternal formulation designed for optimized nutrient absorption and wound healing
|
US5605893A
(en)
|
1994-03-15 |
1997-02-25 |
Children's Hospital Of Los Angeles |
Method of using a therapeutic food composition to diminish blood sugar fluctuations in diabetic patients
|
US5643880A
(en)
|
1994-05-26 |
1997-07-01 |
Abbott Laboratories |
Product for inhibition of attachment of H. influenzae to human cells
|
AU691362B2
(en)
|
1994-11-04 |
1998-05-14 |
New Zealand Dairy Board |
Method of selecting non-diabetogenic milk or milk products and milk or milk products so selected
|
US5821217A
(en)
|
1995-10-27 |
1998-10-13 |
Beth Israel Deaconess Medical Center, Inc. |
Enteral formulation: low in fat and containing protein hydrolysates
|
IT1277964B1
(it)
|
1995-12-27 |
1997-11-12 |
Biosistema Di Pier Luigi Spara |
Prodotto derivato da latte, sostanzialmente esente da betacaseina di mammifero non umano e relativo uso
|
KR100194074B1
(ko)
|
1996-02-21 |
1999-06-15 |
박종헌 |
글루텐 펩타이드를 유효성분으로 포함하는 미네랄 흡수 촉진제
|
IL127684A0
(en)
|
1996-07-17 |
1999-10-28 |
Nicada Inc |
Composition for appetite suppression
|
KR100221124B1
(ko)
|
1996-09-23 |
1999-10-01 |
한상기 |
신규한 카제인 및 그 제조방법
|
NL1005037C2
(nl)
|
1997-01-17 |
1998-07-20 |
Nl Zuivelonderzoek Inst |
Werkwijze voor het selectief afbreken van melkeiwit, in het bijzonder voor het selectief hydrolyseren van caseïne/caseïnaat in aanwezigheid van andere melkeiwitten, in het bijzonder wei-eiwitten.
|
EP1106181A4
(en)
|
1998-08-12 |
2004-12-15 |
Morinaga Milk Industry Co Ltd |
NUTRITIONAL COMPOSITION TO PREVENT HYPERLIPOPROTEINEMIA
|
US6077558A
(en)
|
1998-12-23 |
2000-06-20 |
Bristol-Myers Squibb Company |
Elemental nutritional products
|
US6905702B1
(en)
|
1999-11-08 |
2005-06-14 |
Children's Hospital Los Angeles |
Methods for regulating blood glucose and appetite suppression in type 2 diabetics
|
GB9927603D0
(en)
|
1999-11-22 |
2000-01-19 |
Nestle Sa |
Use of a milk protein hydrolysate in the treatment of diabetes
|
DE69930464D1
(de)
|
1999-12-30 |
2006-05-11 |
Kerry Group Services Ltd |
Aufbaupräparat, das Kohlenhydrat- und Peptidmaterial enthält und sein Gebrauch als Energieergänzung nach oder während körperlicher Übung oder als metabolischer Nährstoff für die orale Verabreichung
|
NL1014380C2
(nl)
|
2000-02-14 |
2001-08-15 |
Friesland Brands Bv |
Darmwandversterkend voedingsmiddel.
|
US6207638B1
(en)
|
2000-02-23 |
2001-03-27 |
Pacifichealth Laboratories, Inc. |
Nutritional intervention composition for enhancing and extending satiety
|
US7666996B2
(en)
|
2000-03-01 |
2010-02-23 |
Peptera Pharmaceuticals Ltd |
Casein derived peptides and uses thereof
|
IL134830A0
(en)
|
2000-03-01 |
2001-05-20 |
Chay 13 Medical Res Group N V |
Peptides and immunostimulatory and anti-bacterial pharmaceutical compositions containing them
|
TWI268138B
(en)
|
2000-05-11 |
2006-12-11 |
Kanebo Seiyaku Ltd |
Composition containing peptide and electrolyte excretion enhancing substance, and food containing the same
|
AU2001234090B2
(en)
|
2000-06-28 |
2007-03-15 |
Fuji Nihon Seito Corporation |
Novel inulin synthase and process for producing inulin by using the same
|
GB0016189D0
(en)
|
2000-06-30 |
2000-08-23 |
Pepsyn Ltd |
Cosmetic composition
|
AU9037401A
(en)
|
2000-09-08 |
2002-03-22 |
New Zealand Dairy Board |
Milk containing beta-casein with proline at position 67 does not aggravate neurological disorders
|
WO2002032231A1
(en)
|
2000-10-19 |
2002-04-25 |
Edens, Luppo |
Protein hydrolysates
|
WO2003005836A2
(en)
|
2001-07-10 |
2003-01-23 |
Trustees Of Boston University |
Modified-fat nutritional products useful for preventing or treating obesity
|
EP1406509B1
(en)
|
2001-07-18 |
2007-09-12 |
DSM IP Assets B.V. |
Process for the hydrolysis of milk proteins
|
DE10149668A1
(de)
|
2001-10-09 |
2003-04-10 |
Numico Res B V |
Insulinmimetische Aminosäuresequenzen
|
JP2003137804A
(ja)
|
2001-10-31 |
2003-05-14 |
Morinaga Milk Ind Co Ltd |
インターロイキン−18誘導剤
|
AU2002366037B2
(en)
|
2001-11-21 |
2005-11-03 |
Morinaga Milk Industry Co., Ltd. |
Novel peptide having angiotensin convertase inhibitory effect
|
EP1359157A1
(en)
|
2002-04-29 |
2003-11-05 |
Société des Produits Nestlé S.A. |
Metallo-proteinase inhibitory agent
|
US7460960B2
(en)
|
2002-05-10 |
2008-12-02 |
Epitome Biosystems, Inc. |
Proteome epitope tags and methods of use thereof in protein modification analysis
|
US20050256057A1
(en)
|
2002-06-04 |
2005-11-17 |
Luppo Edens |
Protein hydrolysate rich in tripeptides
|
FR2841473B1
(fr)
|
2002-06-27 |
2004-09-17 |
Ingredia |
Utilisation d'au moins un peptide de la caseine s2 a activite inhbitrice de l'enzyme de conversion de l'engiotensine i pour la preparation de medicaments, d'aliments et de complements alimentaires
|
EP1534314B1
(en)
|
2002-09-04 |
2014-10-22 |
DSM IP Assets B.V. |
A nutritional and therapeutic composition of an insulin sensitizer and a peptide fraction
|
TWI317636B
(en)
|
2002-11-22 |
2009-12-01 |
Meiji Dairies Corp |
Nutritional compositions for liver disease patients or for patients underhigh levels of invasive stress
|
AU2003277644A1
(en)
|
2002-11-29 |
2004-06-23 |
Morinaga Milk Industry Co., Ltd. |
Cysteine protease inhibitor
|
DE60335216D1
(de)
|
2002-12-29 |
2011-01-13 |
Nissan Chemical Ind Ltd |
Adiponektin-rezeptor und dafür kodierendes gen
|
ZA200507880B
(en)
|
2003-05-05 |
2006-12-27 |
Unilever Plc |
Hydrolysed casein product comprising tripeptides IPP and/or VPP
|
HUE044812T2
(hu)
|
2003-09-23 |
2019-11-28 |
Dsm Ip Assets Bv |
Prolinspecifikus endoproteázok alkalmazása peptidek és fehérjék hidrolízisére
|
RU2388478C2
(ru)
|
2003-10-24 |
2010-05-10 |
Н.В. Нютрисиа |
Иммуномодулирующие олигосахариды
|
BE1015863A6
(nl)
|
2004-01-19 |
2005-10-04 |
Huybrechts Lucas |
Anticariogene proteinen & peptiden & sacchariden.
|
AU2005207891B2
(en)
|
2004-01-28 |
2010-04-01 |
Andromeda Biotech Ltd. |
Hsp therapy in conjunction with a low antigenicity diet
|
EP1568707A1
(en)
|
2004-02-26 |
2005-08-31 |
Puleva Biotech, S.A. |
Antihypertensive peptides from casein hydrolysates
|
MXPA06010014A
(es)
|
2004-03-01 |
2007-03-07 |
Peptera Pharmaceuticals Ltd |
Peptidos derivados de la caseina y usos terapeuticos de los mismos.
|
WO2005117933A1
(en)
|
2004-05-27 |
2005-12-15 |
Campina Nederland Holding B.V. |
Use of protein hydrolysates for the manufacture of a medicament for prophylaxis and/or treatment of a dpp-iv mediated condition
|
US8252769B2
(en)
*
|
2004-06-22 |
2012-08-28 |
N. V. Nutricia |
Intestinal barrier integrity
|
DE102004040452A1
(de)
|
2004-08-20 |
2006-02-23 |
N.V. Nutricia |
Peptidgemisch
|
KR100560127B1
(ko)
|
2004-09-04 |
2006-03-13 |
한국기초과학지원연구원 |
인산화 단백질 분석용 겔-내 표지화 및 겔-내 단리 방법및 이를 이용한 단백질의 인산화 위치 동정 방법
|
EP1811867A2
(en)
|
2004-11-12 |
2007-08-01 |
N.V. Nutricia |
Food composition comprising a protein- and a lipid fraction for rapidly attenuating inflammatory responses
|
DK1831361T3
(da)
|
2004-12-23 |
2012-05-14 |
Campina Nederland Holding Bv |
Proteinhydrolysat beriget med peptider, som inhiberer DPP-IV, og deres anvendelse
|
ATE491349T1
(de)
|
2005-01-18 |
2011-01-15 |
Dsm Ip Assets Bv |
Neue nutrazeutika-zusammensetzungen
|
US8129337B2
(en)
|
2005-02-03 |
2012-03-06 |
Dsm Ip Assets B.V. |
Compositions comprising epigallocatechin gallate and protein hydrolysate
|
AU2006212485B2
(en)
|
2005-02-09 |
2010-03-11 |
Unilever Plc |
Food products comprising hydrolysed milk solids with improved taste
|
DE602006020028D1
(de)
|
2005-04-28 |
2011-03-24 |
Unilever Nv |
Gesundheitsfördernde peptide und sie enthaltende zusammensetzungen
|
US20090131331A1
(en)
|
2005-04-28 |
2009-05-21 |
Dsm Ip Assets B.V. |
Novel Nutraceutical Compositions
|
US20090074893A1
(en)
|
2005-04-29 |
2009-03-19 |
Campina Nederland Holding B.V. |
Antiviral peptides
|
ES2319475B1
(es)
|
2005-06-08 |
2010-02-16 |
Consejo Superior Investig. Cientificas |
Peptidos bioactivos identificados en hidrolizados enzimaticos de caseinas lacteas y procedimiento de obtencion.
|
ES2350907T3
(es)
|
2005-07-01 |
2011-01-28 |
N.V. Nutricia |
Nutrición para bebés con proteínas hidrolizadas.
|
GB0523806D0
(en)
|
2005-11-23 |
2006-01-04 |
Micromass Ltd |
Mass spectrometer
|
US8431531B2
(en)
|
2005-11-30 |
2013-04-30 |
Campina Nederland Holding B.V. |
Methods for stimulating glucagon-like peptide-1(GLP-1) secretion and treatments comprising same
|
WO2008054192A1
(en)
|
2006-11-02 |
2008-05-08 |
N.V. Nutricia |
Use of nutritional compositions for preventing disorders
|
PT1800675E
(pt)
|
2005-12-23 |
2011-08-30 |
Nutricia Nv |
COMPOSIÇÃO CONTENDO ÁCIDOS GORDOS POLI-INSATURADOS, PROTEÍNAS E MANGANjS E/OU MOLIBDÉNIO PARA O MELHORAMENTO DA COMPOSIÇÃO DA MEMBRANA
|
EP1992354B1
(en)
|
2006-02-09 |
2014-04-09 |
Calpis Co., Ltd. |
Rheumatoid arthritis-preventive agent for oral intake
|
EP2007792A2
(en)
|
2006-03-22 |
2008-12-31 |
DSMIP Assets B.V. |
Cholesterol lowering protein hydrolysates
|
WO2007116091A1
(en)
|
2006-04-12 |
2007-10-18 |
Dsm Ip Assets B.V. |
Novel nutraceutical compositions
|
CN101426513B
(zh)
|
2006-04-21 |
2013-05-01 |
株式会社明治 |
含有肽作为有效成分的组合物
|
NZ594814A
(en)
|
2006-04-28 |
2013-03-28 |
Megmilk Snow Brand Co Ltd |
Peptide that is derived from a milk protein and has an antioxidative effect and also acts as a blood adiponectin level increase promotion and/or decrease inhibition agent
|
KR20080003637A
(ko)
|
2006-07-03 |
2008-01-08 |
한상기 |
다이어트효과가 우수한 기능성 유산균발효조성물
|
EP2164349B1
(en)
|
2006-08-04 |
2014-09-10 |
SHS International Ltd. |
Protein free formula
|
WO2008017415A1
(en)
|
2006-08-09 |
2008-02-14 |
Dsm Ip Assets B.V. |
Casein complexes
|
NL1032840C2
(nl)
|
2006-11-09 |
2008-05-13 |
Friesland Brands Bv |
Probiotische hydrolysaatvoeding voor kinderen.
|
NL1033521C2
(nl)
|
2007-03-08 |
2008-09-09 |
Friesland Brands Bv |
Kindervoedingen met geoptimaliseerde aminozuursamenstelling.
|
CN101547706B
(zh)
|
2007-04-12 |
2013-07-10 |
延世大学校产学协力团 |
包含含锌磁性金属氧化物纳米颗粒的磁共振成像造影剂
|
CN101802197A
(zh)
|
2007-05-14 |
2010-08-11 |
比奥根艾迪克Ma公司 |
单链FC(ScFc)区、包含其的结合多肽及与其相关的方法
|
WO2008147562A2
(en)
|
2007-05-25 |
2008-12-04 |
Childrens's Medical Center Corporation |
Dietary formulations and methods for treatment of inflammation and other disorders
|
WO2008153429A2
(en)
|
2007-06-11 |
2008-12-18 |
Uniwersytet Jagiellonski |
A protease from staphylococcus aureus, particularly spia or spib, peptides it recognises and their use
|
EP2187916A2
(en)
|
2007-09-11 |
2010-05-26 |
Mondobiotech Laboratories AG |
Use of gluten exorphin c as a therapeutic agent
|
JP5620106B2
(ja)
|
2007-10-24 |
2014-11-05 |
株式会社糖鎖工学研究所 |
増強されたエフェクター機能を有するポリペプチド
|
PT2285387E
(pt)
*
|
2008-06-13 |
2016-02-09 |
Nutricia Nv |
Nutrição para a prevenção de infeções
|
US8859210B2
(en)
|
2008-10-17 |
2014-10-14 |
Mead Johnson Nutrition Company |
Method for identifying allergenic proteins and peptides
|
JP5735734B2
(ja)
|
2009-04-16 |
2015-06-17 |
雪印メグミルク株式会社 |
脂質代謝改善剤
|
EP2253324A1
(en)
|
2009-04-30 |
2010-11-24 |
Consejo Superior De Investigaciones Cientificas |
Use of a casein-derived peptide and compositions thereof as antihypertensive
|
EP2295535A1
(en)
|
2009-09-11 |
2011-03-16 |
Mead Johnson Nutrition Company |
Probiotic material
|
ES2524067T3
(es)
|
2009-12-04 |
2014-12-03 |
Mjn U.S. Holdings Llc |
Formulación nutricional que comprende un hidrolizado que contiene péptidos de leche de vaca y/o péptidos derivados del mismo para la inducción de tolerancia
|
ES2569241T5
(es)
|
2010-01-19 |
2019-09-11 |
Abbott Lab |
Una composición que comprende Lactobacillus rhamnosus HN001 y prebióticos para su uso en el tratamiento de la enfermedad pulmonar alérgica
|
CA2790996A1
(en)
|
2010-02-24 |
2011-09-01 |
Morinaga Milk Industry Co. Ltd. |
Therapeutic agent for eating disorders
|
SG10202110501RA
(en)
*
|
2010-12-31 |
2021-11-29 |
Abbott Lab |
Methods For Decreasing The Incidence Of Necrotizing Enterocolitis In Infants, Toddlers, Or Children Using Human Milk Oligosaccharides
|
EP2514435A1
(en)
|
2011-04-19 |
2012-10-24 |
Nestec S.A. |
Infant formula for use in the prevention of cardiovascular diseases
|